{"abdominal symptom": 22.4, "accidental overdose": 3.48, "acute disseminated encephalomyelitis": 9.96, "alanine aminotransferase increased": 2.22, "allergy to metals": 23.27, "aspartate aminotransferase increased": 2.18, "autoimmune disorder": 3.02, "autoimmune hepatitis": 3.78, "autoimmune thyroiditis": 7.99, "chromaturia": 2.91, "chronic fatigue syndrome": 6.45, "circulatory collapse": 9.95, "conjunctivitis": 2.17, "coordination abnormal": 4.31, "demyelination": 6.55, "dermatitis allergic": 3.12, "diplopia": 2.07, "disability": 6.51, "dysaesthesia": 4.43, "eczema": 2.04, "encephalitis": 5.09, "epilepsy": 2.21, "expired product administered": 3.82, "extra dose administered": 7.63, "facial paresis": 11.21, "formication": 6.39, "gamma-glutamyltransferase increased": 5.4, "gastroenteritis": 2.3, "generalised tonic-clonic seizure": 3.42, "guillain-barre syndrome": 8.77, "henoch-schonlein purpura": 9.7, "hepatic enzyme increased": 8.37, "hepatic steatosis": 2.81, "hepatitis": 3.55, "hepatitis a": 145.91, "hepatitis a antibody negative": 1079.98, "hepatitis b": 15.29, "hepatitis b antibody negative": 834.32, "hepatitis b surface antibody negative": 424.81, "hypersensitivity": 2.68, "hypoaesthesia": 2.3, "hypokinesia": 2.18, "impaired work ability": 2.4, "inappropriate schedule of product administration": 4.03, "incomplete course of vaccination": 13.91, "infection susceptibility increased": 6.31, "injection site induration": 2.43, "jaundice": 4.38, "lichen planus": 6.84, "listless": 4.52, "local reaction": 4.14, "loss of consciousness": 2.16, "meningitis": 4.36, "monoplegia": 3.76, "movement disorder": 3.42, "multiple sclerosis": 10.91, "muscle twitching": 2.3, "muscular weakness": 2.57, "myelitis": 11.66, "myelitis transverse": 8.65, "myositis": 3.59, "nervous system disorder": 2.5, "neuritis": 17.82, "neurodermatitis": 9.16, "ocular icterus": 10.17, "optic neuritis": 10.87, "pallor": 3.51, "paraesthesia": 2.47, "paralysis": 3.96, "paresis": 7.95, "performance status decreased": 4.92, "peripheral vascular disorder": 4.86, "polyarthritis": 4.18, "polyneuropathy": 4.84, "product administered to patient of inappropriate age": 18.25, "product complaint": 29.06, "quadriparesis": 18.13, "radiculopathy": 11.12, "seasonal allergy": 10.48, "sensory disturbance": 4.85, "sensory loss": 2.55, "somatic symptom disorder": 10.55, "syncope": 2.09, "syringe issue": 8.59, "therapeutic response decreased": 7.68, "therapy non-responder": 16.3, "transaminases increased": 7.27, "underdose": 17.37, "urticaria": 2.38, "vaccination complication": 59.32, "vaccination site granuloma": 13.05, "vasculitis": 3.08, "visual field defect": 3.71, "visual impairment": 2.03, "wrong product administered": 5.27}